VIA
BCYC

Virtus Investment Advisers’s Bicycle Therapeutics BCYC Stock Holding History

Virtus Investment Advisers’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$170K Buy
36,601
+892
+2% +$5.1K 0.05% 435
2025
Q4 		$253K Buy
35,709
+22,615
+173% +$167K 0.07% 321
2025
Q3 		$101K Buy
13,094
+2,273
+21% +$17.2K 0.03% 423
2025
Q2 		$75.2K Buy
10,821
+2,659
+33% +$21.2K 0.03% 433
2025
Q1 		$69.3K Buy
+8,162
New +$96.2K 0.02% 457

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtus Investment Advisers's BCYC Position: Q1 2026 in Review

Virtus Investment Advisers increased its Bicycle Therapeutics (BCYC) stake by 2.5% in Q1 2026, buying an estimated $5.1K and bringing the position to 36,601 shares worth $170K. The position accounts for 0.05% of the portfolio, ranked #435.

Virtus Investment Advisers first reported a position in BCYC in Q1 2025 and has held it in 5 quarters since. The position peaked at $253K in Q4 2025. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Virtus Investment Advisers held 36,601 shares of Bicycle Therapeutics worth $170K as of Q1 2026.
  • Virtus Investment Advisers bought 892 Bicycle Therapeutics shares in Q1 2026, an estimated $5.1K.
  • Bicycle Therapeutics made up 0.05% of Virtus Investment Advisers's portfolio in Q1 2026, its #435 holding.
  • Virtus Investment Advisers first reported a position in Bicycle Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Virtus Investment Advisers's Bicycle Therapeutics position peaked at $253K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.